Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Market Cap

Sarepta Therapeutics has a market cap or net worth of $2.46 billion as of January 7, 2026. Its market cap has decreased by -78.60% in one year.

• Market Cap: 2.46B
• Enterprise Value: 2.93B
• 1-Year Change: -78.60%
• Ranking: #1924
• Category: Mid-Cap
• Stock Price: $23.46

Market Cap Chart

Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $2.46B, an increase of 4,109.43%. That is a compound annual growth rate of 14.79%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	2.34B	3.86%
Dec 31, 2025	2.26B	-80.58%
Dec 31, 2024	11.61B	28.75%
Dec 29, 2023	9.02B	-20.70%
Dec 30, 2022	11.37B	45.06%
Dec 31, 2021	7.84B	-41.72%
Dec 31, 2020	13.45B	39.87%
Dec 31, 2019	9.62B	31.90%
Dec 31, 2018	7.29B	102.79%
Dec 29, 2017	3.60B	140.16%
Dec 30, 2016	1.50B	-14.27%
Dec 31, 2015	1.75B	192.17%
Dec 31, 2014	597.80M	-21.92%
Dec 31, 2013	765.60M	16.58%
Dec 31, 2012	656.70M	549.55%
Dec 30, 2011	101.10M	-57.54%
Dec 31, 2010	238.10M	47.70%
Dec 31, 2009	161.20M	244.44%
Dec 31, 2008	46.80M	-38.26%
Dec 31, 2007	75.80M	-54.99%
Dec 29, 2006	168.40M	10.50%
Dec 30, 2005	152.40M	79.51%
Dec 31, 2004	84.90M	-33.15%
Dec 31, 2003	127.00M	-3.93%
Dec 31, 2002	132.20M	-47.73%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.72B
Johnson & Johnson	493.40B
AbbVie	395.77B
UnitedHealth Group	316.11B
AstraZeneca	293.89B
Merck & Co.	270.22B
Novartis AG	268.87B
Novo Nordisk	253.02B